Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study

Authors: Maiorano, Brigida Anna ^{1, a, ⁎}, Catalano, Martina ^{2, a}, Mercinelli, Chiara ^{1, 3, a}, Roviello, Giandomenico ², Maruzzo, Marco ⁴, De Giorgi, Ugo ⁵, Chiellino, Silvia ⁶, Sbrana, Andrea ⁷, Galli, Luca ³, Zucali, Paolo Andrea ^{8, 9}, Masini, Cristina ¹⁰, Naglieri, Emanuele ¹¹, Procopio, Giuseppe ¹², Merler, Sara ¹³, Fratino, Lucia ¹⁴, Baldessari, Cinzia ¹⁵, Ricotta, Riccardo ¹⁶, Mollica, Veronica ¹⁷, Sorarù, Mariella ¹⁸, Tudini, Marianna ¹⁹, Prati, Veronica ²⁰, Malgeri, Andrea ²¹, Atzori, Francesco ²², Napoli, Marilena Di ²³, Caffo, Orazio ²⁴, Spada, Massimiliano ²⁵, Morelli, Franco ²⁶, Prati, Giuseppe ²⁷, Nolè, Franco ²⁸, Vignani, Francesca ²⁹, Cavo, Alessia ³⁰, Lipari, Helga ³¹, Puglisi, Silvia ³², Signori, Alessio ³³, Necchi, Andrea ^{1, 34}, Banna, Giuseppe Luigi ^{35, 36}, Fornarini, Giuseppe ³⁷, Buti, Sebastiano ^{38, 39, b}, Rebuzzi, Sara Elena ^{40, b}

Source: In Clinical Genitourinary Cancer February 2025 23(1)

Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide

Authors: Caffo, Orazio ^{1, ⁎}, Basso, Umberto ², Cattrini, Carlo ³, Ermacora, Paola ⁴, Maruzzo, Marco ², Alberti, Martina ⁴, Anesi, Cecilia ¹, Bimbatti, Davide ², Cani, Massimiliano ⁵, Crespi, Veronica ⁵, Farinea, Giovanni ⁵, Kadrija, Dzenete ¹, Kinspergher, Stefania ¹, Lai, Eleonora ⁶, Lay, Ludovica ⁴, Maines, Francesca ¹, Mennitto, Alessia ³, Pierantoni, Francesco ⁶, Samuelly, Alessandro ⁵, Urban, Susanna ⁴, Buttigliero, Consuelo ⁵, Veccia, Antonello ¹

Source: In Clinical Genitourinary Cancer February 2025 23(1)

Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study

Authors: Guida, Annalisa, Gili, Alessio, Mosillo, Claudia, Maruzzo, Marco, Lai, Eleonora, Pierantoni, Francesco, Bimbatti, Davide, Basso, Umberto, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Calabrò, Fabio, Cerbone, Linda, Caserta, Claudia, Sirgiovanni, Grazia, Serafin, Debora, Caffo, Orazio, Scagliarini, Sarah, Bracarda, Sergio

Source: In Clinical Genitourinary Cancer December 2024 22(6)

Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group

Authors: Toss, Angela ^{a, b, 1, ⁎}, Piombino, Claudia ^{a, 1}, Quarello, Paola ^c, Trama, Annalisa ^d, Mascarin, Maurizio ^e, Lambertini, Matteo ^{f, g}, Canesi, Marta ^h, Incorvaia, Lorena ⁱ, Milano, Giuseppe Maria ^j, Maruzzo, Marco ^k, Perrone, Francesco ^l, Peccatori, Fedro ^{m, 2}, Ferrari, Andrea ^{n, 2}

Source: In European Journal of Cancer November 2024 212

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

Authors: Iacovelli, Roberto, Ciccarese, Chiara, Buti, Sebastiano, Zucali, Paolo Andrea, Fantinel, Emanuela, Bimbatti, Davide, Verzoni, Elena, Accettura, Caterina, Bonomi, Lucia, Buttigliero, Consuelo, Fornarini, Giuseppe, Pipitone, Stefania, Atzori, Francesco, Masini, Cristina, Massari, Francesco, Primi, Francesca, Strusi, Alessandro, Giudice, Giulia Claire, Perrino, Matteo, Maruzzo, Marco, Milella, Michele, Giannarelli, Diana, Brunelli, Matteo, Procopio, Giuseppe, Tortora, Giampaolo

Source: In European Urology November 2024 86(5):411-419

Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney

Authors: Giudice, Giulia Claire ^{1, 2, ⁎}, Maruzzo, Marco ³, Verzoni, Elena ⁴, Procopio, Giuseppe ⁴, Bimbatti, Davide ³, Sepe, Pierangela ⁴, Maines, Francesca ⁵, Grillone, Francesco ⁶, Cavo, Alessia ⁷, Santoni, Matteo ⁸, Cordua, Nadia ⁹, Pecoraro, Giovanna ¹⁰, Prati, Veronica ¹¹, Napoli, Marilena Di ¹², Ollari, Eli ², Caruso, Giuseppe ¹, Simoni, Nicola ¹³, Campobasso, Davide ¹⁴, Buti, Sebastiano ^{1, 2}

Source: In Clinical Genitourinary Cancer October 2024 22(5)

Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)

Authors: Gambale, Elisabetta, Maruzzo, Marco, Messina, Carlo, De Gennaro Aquino, Irene, Vascotto, Ismaela Anna, Rossi, Virginia, Bimbatti, Davide, Cavasin, Nicolò, Messina, Marco, Mennitto, Alessia, Rebuzzi, Sara Elena, Nasso, Cecilia, Mercinelli, Chiara, Maiorano, Brigida Anna, Fanelli, Martina, Sorarù, Mariella, Scolari, Federico, Mela, Marinella Micol, Galli, Luca, Salfi, Alessia, Rizzo, Mimma, Puglisi, Silvia, Orlando, Valentina, Fornarini, Giuseppe, Rametta, Alessandro, Giannatempo, Patrizia, Cerbone, Linda, Doni, Laura, Roviello, Giandomenico, Pillozzi, Serena, Antonuzzo, Lorenzo

Source: In Clinical Genitourinary Cancer August 2024 22(4)

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies

Authors: Altavilla, Amelia, Atzori, Francesco, Banna, Giuseppe Luigi, Barni, Sandro, Basso, Umberto, Bauckneht, Matteo, Berardi, Rossana, Berruti, Alfredo, Bertoldo, Francesco, Bimbatti, Davide, Boccardo, Francesco, Buti, Sebastiano, Buttigliero, Consuelo, Caffo, Orazio, Calabrò, Fabio, Cattrini, Carlo, Cellini, Francesco, Conteduca, Vincenza, Cursano, Maria Concetta, De Feo, Giulia, De Giorgi, Ugo, Di Lorenzo, Giuseppe, Di Maio, Massimo, Di Napoli, Marilena, Ermacora, Paola, Fornarini, Giuseppe, Fratino, Lucia, Fusco, Vittorio, Gernone, Angela, Ibrahim, Toni, Lanzetta, Gaetano, Malgeri, Andrea, Maruzzo, Marco, Masini, Cristina, Messina, Carlo, Mosca, Alessandra, Naglieri, Emanuele, Nolè, Franco, Ortega, Cinzia, Palermo, Andrea, Pantano, Francesco, Prati, Veronica, Procopio, Giuseppe, Rescigno, Pasquale, Roberto, Michela, Rossetti, Sabrina, Roviello, Giandomenico, Santini, Daniele, Stellato, Marco, Tambaro, Rosa, Toma, Ilaria, Tucci, Marcello, Valsecchi, Anna Amela, Verzoni, Elena, Zanardi, Elisa, Zucali, Paolo Andrea, Cursano, M.C., Valsecchi, A.A., Pantano, F., Di Maio, M., Procopio, G., Berruti, A., Bertoldo, F., Tucci, M., De Giorgi, U., Santini, D.

Source: In ESMO Open July 2024 9(7)

Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27

Authors: Stellato, Marco, Buti, Sebastiano, Maruzzo, Marco, Bassanelli, Maria, Bersanelli, Melissa, Napoli, Marilena Di, Dionese, Michele, Fanelli, Martina, Filippi, Roberto, Fotia, Giuseppe, Galli, Luca, Grillone, Francesco, Maffezzoli, Michele, Maiorano, Brigida Anna, Nasso, Cecilia, Rebuzzi, Sara Elena, Lalli, Luca, Roviello, Giandomenico, Sorarù, Mariella, Vincenzi, Bruno, Procopio, Giuseppe, Verzoni, Elena

Source: In Clinical Genitourinary Cancer June 2024 22(3)

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

Authors: Mollica, Veronica, Massari, Francesco, Maruzzo, Marco, Bimbatti, Davide, Claps, Melanie, Maiorano, Brigida Anna, Vitale, Maria Giuseppa, Iacovelli, Roberto, Ermacora, Paola, Roviello, Giandomenico, Calabrò, Fabio, Caffo, Orazio, Vignani, Francesca, Grillone, Francesco, Pierantoni, Francesco, Di Napoli, Marilena, Mennitto, Alessia, Marchetti, Andrea, Mattana, Alvise, Cavo, Alessia, Bassanelli, Maria, Formisano, Luigi, Prati, Veronica, Giudice, Giulia Claire, Buti, Sebastiano

Source: In Clinical Genitourinary Cancer June 2024 22(3)

Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)

Authors: Damassi, Alessandra, Cremante, Malvina, Signori, Alessio, Rebuzzi, Sara Elena, Fornarini, Giuseppe, Giudice, Giulia Claire, Maruzzo, Marco, Procopio, Giuseppe, Sorarù, Mariella, Di Napoli, Marilena, Fratino, Lucia, Santini, Daniele, Grillone, Francesco, Ballestrin, Melissa, Dionese, Michele, Nasso, Cecilia, Catalano, Fabio, Murianni, Veronica, Rescigno, Pasquale, Anpalakhan, Shobana, Banna, Giuseppe Luigi, Basso, Umberto, Buti, Sebastiano

Source: In Clinical Genitourinary Cancer April 2024 22(2):126-133

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Authors: Santoni, Matteo, Buti, Sebastiano, Myint, Zin W., Maruzzo, Marco, Iacovelli, Roberto, Pichler, Martin, Kopecky, Jindrich, Kucharz, Jakub, Rizzo, Mimma, Galli, Luca, Büttner, Thomas, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Zucali, Paolo Andrea, Kopp, Ray Manneh, Fornarini, Giuseppe, Bourlon, Maria T., Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, Matrana, Marc R., Pichler, Renate, Cattrini, Carlo, Büchler, Tomas, Massari, Francesco, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristotelis, Caffo, Orazio, Procopio, Giuseppe, Sunela, Kaisa, Bassanelli, Maria, Ortega, Cinzia, Grillone, Francesco, Landmesser, Johannes, Milella, Michele, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Santini, Daniele, Vau, Nuno, Morelli, Franco, Incorvaia, Lorena, Rebuzzi, Sara Elena, Roviello, Giandomenico, Soares, Andrey, Bisonni, Renato, Bimbatti, Davide, Zabalza, Ignacio Ortego, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Monteiro, Fernando Sabino M., Battelli, Nicola, Bracarda, Sergio, Porta, Camillo

Source: In European Urology Oncology February 2024 7(1):102-111

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis

Authors: Anpalakhan, Shobana, Signori, Alessio, Cortellini, Alessio, Verzoni, Elena, Giusti, Raffaele, Aprile, Giuseppe, Ermacora, Paola, Catino, Annamaria, Pipitone, Stefania, Di Napoli, Marilena, Scotti, Vieri, Mazzoni, Francesca, Guglielmini, Pamela F., Veccia, Antonello, Maruzzo, Marco, Schinzari, Giovanni, Casadei, Chiara, Grossi, Francesco, Rizzo, Mimma, Montesarchio, Vincenzo, Verderame, Francesco, Mencoboni, Manlio, Zustovich, Fable, Fratino, Lucia, Accettura, Caterina, Cinieri, Saverio, Tondini, Carlo Alberto, Camerini, Andrea, Banzi, Maria Chiara, Sorarù, Mariella, Zucali, Paolo Andrea, Vignani, Francesca, Ricciardi, Serena, Russo, Antonio, Cosenza, Agnese, Di Maio, Massimo, De Giorgi, Ugo, Pignata, Sandro, Giannarelli, Diana, Pinto, Carmine, Buti, Sebastiano, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Rescigno, Pasquale, Addeo, Alfredo, Banna, Giuseppe L., Bersanelli, Melissa

Source: In iScience 17 November 2023 26(11)

Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model

Authors: Buja, Alessandra, De Luca, Giuseppe, Gatti, Maura, Bonaldi, Filippo, Gardi, Mario, Bortolami, Alberto, Sepulcri, Matteo, Bimbatti, Davide, Baldo, Vincenzo, Scioni, Manuela, Maruzzo, Marco, Basso, Umberto, Zagonel, Vittorina

Source: Clinical genitourinary cancer. 21(4):e252-e260

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194493526.0x000001&indx=1&recIds=ETOCvdc_100194493526.0x000001

Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1

Authors: Saad, Fred, de Bono, Johann, Barthélémy, Philippe, Dorff, Tanya, Mehra, Niven, Scagliotti, Giorgio, Stirling, Adam, Machiels, Jean-Pascal, Renard, Vincent, Maruzzo, Marco, Higano, Celestia S., Gurney, Howard, Healy, Cynthia, Bhattacharyya, Helen, Arondekar, Bhakti, Niyazov, Alexander, Fizazi, Karim

Source: European urology. 83(4):352-360

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185105672.0x000001&indx=1&recIds=ETOCvdc_100185105672.0x000001

Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication

Authors: Buti, Sebastiano, Basso, Umberto, Giannarelli, Diana, De Giorgi, Ugo, Maruzzo, Marco, Iacovelli, Roberto, Galli, Luca, Porta, Camillo, Carrozza, Francesco, Procopio, Giuseppe, Fonarini, Giuseppe, Lo Re, Giovanni, Santoni, Matteo, Sabbatini, Roberto, Cusmai, Antonio, Zucali, Paolo Andrea, Aschele, Carlo, Baldini, Editta, Zafarana, Elena, Favaretto, Adolfo, Leo, Silvana, Hamzaj, Alketa, Mirabelli, Rosanna, Nole', Franco, Zai, Silvia, Chini, Claudio, Masini, Cristina, Fatigoni, Sonia, Rocchi, Andrea, Tamburini, Emiliano, Cortellini, Alessio, Bersanelli, Melissa

Source: Journal of immunotherapy. 46(1):22-26

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178862237.0x000001&indx=1&recIds=ETOCvdc_100178862237.0x000001

The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma

Authors: Pierantoni, Francesco, Dionese, Michele, Basso, Umberto, Lai, Eleonora, Cavasin, Nicolò, Erbetta, Elisa, Mattana, Alvise, Bimbatti, Davide, Zagonel, Vittorina, Lonardi, Sara, Maruzzo, Marco

Source: In Clinical Genitourinary Cancer October 2023 21(5):e378-e385

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

Authors: Bersanelli, Melissa, Verzoni, Elena, Cortellini, Alessio, Giusti, Raffaele, Calvetti, Lorenzo, Ermacora, Paola, Di Napoli, Marilena, Catino, Annamaria, Guadalupi, Valentina, Guaitoli, Giorgia, Scotti, Vieri, Mazzoni, Francesca, Veccia, Antonello, Guglielmini, Pamela Francesca, Perrone, Fabiana, Maruzzo, Marco, Rossi, Ernesto, Casadei, Chiara, Montesarchio, Vincenzo, Grossi, Francesco, Rizzo, Mimma, Travagliato Liboria, Maria Grazia, Mencoboni, Manlio, Zustovich, Fable, Fratino, Lucia, Accettura, Caterina, Cinieri, Saverio, Camerini, Andrea, Sorarù, Mariella, Zucali, Paolo Andrea, Ricciardi, Serena, Russo, Antonio, Negrini, Giorgia, Banzi, Maria Chiara, Lacidogna, Gaetano, Fornarini, Giuseppe, Laera, Letizia, Mucciarini, Claudia, Santoni, Matteo, Mosillo, Claudia, Bonetti, Andrea, Longo, Lucia, Sartori, Donata, Baldini, Editta, Guida, Michele, Iannopollo, Mauro, Bordonaro, Roberto, Morelli, Maria Francesca, Tagliaferri, Pierosandro, Spada, Massimiliano, Ceribelli, Anna, Silva, Rosa Rita, Nolè, Franco, Beretta, Giordano, Giovanis, Petros, Santini, Daniele, Luzi Fedeli, Stefano, Nanni, Oriana, Maiello, Evaristo, Labianca, Roberto, Pinto, Carmine, Clemente, Alberto, Tognetto, Michele, De Giorgi, Ugo, Pignata, Sandro, Di Maio, Massimo, Buti, Sebastiano, Giannarelli, Diana

Source: In eClinicalMedicine July 2023 61

Real‐Practice Analysis of Potential Antibiotic Interactions in Patients Treated With Immune Checkpoint Inhibitors: An Observational Study From an Italian Referral Cancer Center.

Authors: Russi, Alberto, Saran, Camilla, Zanchetta, Giulia, Zorzetto, Giorgia, Crivellaro, Giovanna, Maruzzo, Marco, Pasello, Giulia, Fabozzi, Alessio, Toni, Chiara De, Cenzi, Carola, Berti, Elena, Cognolato, Silvia, Pipitone, Francesca, Bortolami, Alberto, Sansone, Alice Capogrosso, Salvato, Chiara, Bano, Francesca, Moretti, Ugo, De Ambrosis, Paola, Scroccaro, Giovanna

Source: Journal of Clinical Pharmacy & Therapeutics; 2/28/2025, Vol. 2025, p1-10, 10p

Subject Terms: THERAPEUTIC use of antineoplastic agents, ANTIBIOTICS, PATIENT compliance, DRUG side effects, RESEARCH funding, SCIENTIFIC observation, DRUG resistance in microorganisms, IMMUNOTHERAPY, TREATMENT effectiveness, RETROSPECTIVE studies, EVALUATION of medical care, IMMUNE checkpoint inhibitors, MONOCLONAL antibodies, DRUG interactions, DRUG efficacy, MEDICAL records, ACQUISITION of data, RESEARCH methodology, TUMORS, PROGRESSION-free survival, NIVOLUMAB, DRUGS, DRUG antagonism, OVERALL survival

Geographic Terms: ITALY

Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).

Authors: Arduini, Daniela, Ciccarese, Chiara, Acunzo, Alessandro, Perrino, Matteo, Maruzzo, Marco, Verzoni, Elena, Accettura, Caterina, Bonomi, Lucia, Buttigliero, Consuelo, Cremante, Malvina, Pipitone, Stefania, Scartozzi, Mario, Masini, Cristina, Mollica, Veronica, Primi, Francesca, Strusi, Alessandro, Buti, Sebastiano, Zucali, Paolo Andrea, Fantinel, Emanuela, Iacovelli, Roberto

Source: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p551-551, 177p